Literature DB >> 23412792

Array-CGH analysis of cutaneous anaplastic large cell lymphoma.

K Szuhai1, R van Doorn, C P Tensen.   

Abstract

This chapter describes a study in which the pattern of numerical chromosomal alterations in cutaneous anaplastic large cell lymphoma (C-ALCL) tumor samples was defined using array-based comparative genomic hybridization (CGH). First, the array-based CGH technique applied is outlined in detail. Next, its application in the analysis of C-ALCL tumor specimens is described. This approach resulted in the identification of highly recurrent chromosomal alterations in C-ALCL that include gain of 7q31 and loss on 6q16-6q21 and 13q34, each affecting 45% of the patients. The pattern characteristic of C-ALCL differs markedly from chromosomal alterations observed in other CTCL such as mycosis fungoides and Sézary syndrome and yielded several candidate genes with potential relevance in the pathogenesis of C-ALCL.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23412792     DOI: 10.1007/978-1-62703-281-0_13

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.

Authors:  Juan Sandoval; Angel Díaz-Lagares; Rocío Salgado; Octavio Servitje; Fina Climent; Pablo L Ortiz-Romero; Amparo Pérez-Ferriols; Maria P Garcia-Muret; Teresa Estrach; Mar Garcia; Lara Nonell; Manel Esteller; Ramon M Pujol; Blanca Espinet; Fernando Gallardo
Journal:  J Invest Dermatol       Date:  2014-11-18       Impact factor: 8.551

Review 2.  CD30-positive primary cutaneous lymphoproliferative disorders: molecular alterations and targeted therapies.

Authors:  Lucia Prieto-Torres; Socorro M Rodriguez-Pinilla; Arantza Onaindia; Mariano Ara; Luis Requena; Miguel Á Piris
Journal:  Haematologica       Date:  2019-01-10       Impact factor: 9.941

Review 3.  Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.

Authors:  Xin-Rui Zhang; Pham-Ngoc Chien; Sun-Young Nam; Chan-Yeong Heo
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.